Morphological Changes in Bone Marrow Post Imatinib Therapy in Chronic Phase CML: A Follow up Study on Sequential Bone Marrow Aspirates and Biopsies

INTRODUCTION: Imatinib mesylate is used extensively for first line treatment of Chronic Myeloid Leukemia (CML). However, not many studies have documented morphological changes in bone marrow biopsies produced during Imatinib therapy with reference to myelofibrosis. AIM: To document the morphological...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Diagn Res
Autors principals: Narang, Neha Chopra, Rusia, Usha, Sikka, Meera, Kotru, Mrinalini
Format: Artigo
Idioma:Inglês
Publicat: JCDR Research and Publications (P) Limited 2017
Matèries:
Pathology Section
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5449791/
https://ncbi.nlm.nih.gov/pubmed/28571145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2017/25173.9650
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars